DesiCorp, Inc.

Amendment
CIK: 0001997477·Biotechnology·DELAWARE·Filed: Jan 16, 2026
Total Offering

$8,000,000

Amount Sold

$5,188,530

Investors

15

First Sale

Jul 3, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)

Related Persons

NameRole
Brett Janis
Executive Officer, Director
Jonathan Kopecheck
Executive Officer, Director
Michael Menze
Executive Officer, Director
Robert Saunders
Director

Company

DesiCorp, Inc.

201 E. JEFFERSON STREET

LOUISVILLE, KY, 40202

(502) 351-0353

SEC Filing

0001997477-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
DesiCorp, Inc. Form D Filing — $8,000,000 | FilingFlow